跳至主要内容
临床试验/NCT01830257
NCT01830257Unknown4 期

Phase 4 Study of MR and APDT Vaccine

Beijing Center for Disease Control and Prevention0 个研究点目标入组 1,000 人开始时间: 2013年4月1日最近更新:
适应症

试验速览

阶段
4 期
发起方
入组人数
1,000
主要终点
Incidence about AEFI

研究概览

简要总结

The investigators would remind the guardians of observation after immunization via sending short message and collect the information of AEFI by two ways, short message/telephone and website questionnaire.

详细描述

The investigators will compare the rate between active and inactive surveillance of AEFI

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • According with the regular vaccination
  • Immunization the acellular pertussis diphtheria tetanus vaccine and Measles and rubella combined vaccine

排除标准

  • Disapproval the AEFI information

结局指标

主要结局

Incidence about AEFI

时间窗: 1.5years

Incidence about AEFI comes from the rate between number of adverse event and the all quantity for immunization about MR and APDT

次要结局

未报告次要终点

研究者

发起方
Beijing Center for Disease Control and Prevention
申办方类型
Other Gov
责任方
Sponsor

相似试验